Research / LYB / Fundamental state Inspectable configuration
State dimensions Filing 0001489393-22-000020 General Corporate
Capex intensity 0th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.47% · OPTIONAL · VALID
Operating cash generation 21th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
11.70% · OPTIONAL · VALID
Revenue growth 80th Own-history percentile · N=15
Evidence method Yoy · gp.fundamentals.revenue
45.07% · CORE · VALID
Inventory pressure 26th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
38.78% · OPTIONAL · VALID
Operating margin 37th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.operating_margin
12.94% · CORE · VALID
R&D intensity 5th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.25% · OPTIONAL · VALID
SBC intensity 35th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.14% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 33 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 4.34%
Current 3.47%
Delta -0.87% Cash Generation Decreased
Previous 17.05%
Current 11.70%
Delta -5.35% Growth Decreased
Previous 67.20%
Current 45.07%
Delta -22.13% Inventory Pressure Increased
Previous 10.86%
Current 38.78%
Delta 27.92% Profitability Decreased
Previous 15.01%
Current 12.94%
Delta -2.07% R And D Intensity Decreased
Previous 0.27%
Current 0.25%
Delta -0.03% Sbc Intensity Decreased
Previous 0.15%
Current 0.14%
Delta -0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.